NCT01669902View on ClinicalTrials.gov

An Observational Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis

CompletedOBSERVATIONAL
Enrollment

107

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Rheumatoid Arthritis
Trial Locations (26)

1346

Gjettum

1535

Moss

3722

Skien

4300

Holbæk

4600

Køge

5053

Bergen

5700

Svendborg

6000

Kolding

6700

Esbjerg

7030

Trondheim

7100

Vejle

29185

Kristianstad

37185

Karlskrona

54185

Skövde

65185

Karlstad

72189

Västerås

75185

Uppsala

SE-791 82

Falun

541 85

Farsta

413 45

Gothenburg

251 87

Helsingborg

824 81

Hudiksvall

551 85

Jönköping

205 02

Malmo

272 81

Simrishamn

231 85

Trelleborg

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01669902 - An Observational Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter